Hard to believe this stock was trading in the high 19s for a good month back in July 2020.
For it to trade at that price for as long as it did means at least some of the big instos saw intrinsic value at those prices on the assumption that Chinese customers would keep buying infant formula by migrating their behavior from Daigou channels to MBS.
When that assumption was proven false, well the share price speaks for itself.
But if they had that assumption in July 2020, right in the middle of the pandemic, then you can make the long term assumption that when the pandemic is over and buying behaviours go back to how they were pre-pandemic, is it so wrong to think this stock won't be back at $20 some time in the future?
At current prices, you are looking at a 50% margin of safety if you take ~$20 as intrinsic value pre-covid. A lot of deep value investors look for a 50% margin of safety when investing long term in a stock and probably a reason why the stock price has shown support around the $10 level.
My opinion only. DYOR
- Forums
- ASX - By Stock
- Chart Update
Hard to believe this stock was trading in the high 19s for a...
- There are more pages in this discussion • 8,495 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
(20min delay)
|
|||||
Last
$6.06 |
Change
0.070(1.17%) |
Mkt cap ! $4.380B |
Open | High | Low | Value | Volume |
$5.99 | $6.11 | $5.96 | $11.09M | 1.834M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6819 | $6.05 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.06 | 500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6819 | 6.050 |
4 | 26955 | 6.030 |
2 | 11610 | 6.020 |
2 | 14857 | 6.010 |
1 | 15000 | 5.970 |
Price($) | Vol. | No. |
---|---|---|
6.060 | 500 | 1 |
6.080 | 12091 | 3 |
6.090 | 10952 | 3 |
6.100 | 8539 | 2 |
6.120 | 24564 | 5 |
Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
$6.06 |
  |
Change
0.070 ( 1.12 %) |
|||
Open | High | Low | Volume | ||
$5.97 | $6.11 | $5.95 | 810802 | ||
Last updated 15.59pm 06/05/2024 ? |
Featured News
A2M (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online